ORGANIZED BY FUNDACIÓN GECP

Similar documents
Gastrointestinal Oncology

PARQUE DE LAS CIENCIAS PROGRAM

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

With the Presidency of Her Majesty the Queen Sofia

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February

FALL MEETING. Sitges, 7th and 8th October, Venue. ME Sitges Terramar Hotel Passeig Marítim, Sitges, Barcelona

21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS

Gastrointestinal Oncology

II CANCER CELL SIGNALING PATHWAYS CONFERENCE

FIRST CANCER CELL SIGNALING PATHWAYS MEETING

EORTC LUNG CANCER GROUP GROUP MEETING

URO. I International Workshop PEYRONIE S DISEASE UPDATED PATTERNS IN CONSERVATIVE MANAGEMENT AND SURGICAL TREATMENT OF. MADRID, 18th JUNE 2015

April 5-6, 2016 Sabadell, Barcelona

21-23 ALICANTE INTERNATIONAL CONGRESS ON RESEARCH AND INNOVATION IN NEURODEGENERATIVE DISEASES CONGRESO INTERNACIONAL

LION-HEART. Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure

CHAIRMAN. - Hernán Cortés-Funes, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain FACULTY

Madrid, 15 th - 16 th November Meeting Venue: Paseo de la Castellana 33, Madrid

Resultados del estudio Concordance: Relevancia clínica de la determinación del ADNtc mediante la tecnología BEAMing. Ana Vivancos

Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd

OBJECTIVES OF THE MEETING

WELCOME. Dear colleagues,

INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

BARIATRIC AND METABOLIC SURGERY

THURSDAY, 9 JUNE 2016

The 2015 Barcelona Congenital Hyperinsulinism Family Conference

Dr. Sergi Call Caja Thoracic Surgery Service

Complete manuscript title: Brain metastases from lung cancer responding to erlotinib: The importance of EGFR mutation

5 Courses: 2002, 2004, 2005, 2006 and 2007 Third period: Directors: Carmen Comas-Gabriel and Bernat Serra (Barcelona)

The OncoBEAM RAS liquid biopsy experience in real-world clinical practice Frederick S. Jones, Ph.D., Global Director, Medical Scientific

ConsEPOC International Meeting

MUSEC Modular Ultrasound ESTES Course. Manresa, May 30th 2015

Articles. Funding Spanish Lung Cancer Group, Roche Farma, Hoffmann-La Roche, and Red Temática de Investigacion Cooperativa en Cancer.

ERJ Express. Published on March 21, 2018 as doi: /

Faculty. Silvia Allende, MD Paulina Núñez, MD Raúl Ramírez, MD Gabriel Santiago, MD Nidia Zapata, MD

Educating in Radiosurgery Course

ESPNIC Endorsed Advanced Simulation Course. Program

in combination with cisplatin as first-line doublet 3 as maintenance agent following non-pemetrexed platinum doublet 4

OBESITY HYPOVENTILATION SYNDROME: CPAP vs NIV. J. F. Masa San Pedro de Alcántara Hospital Cáceres. Spain

Academia Pharma Intersect:

MUSEC Modular Ultrasound ESTES Course. Manresa, May 30th 2015

The Oncologist 2018;23:1271 e128 TRIAL INFORMATION LESSONS LEARNED ABSTRACT. Clinical Trial Results

on Skills Training Workshop in Vascular Access: A Multidisciplinary Approach

original article introduction article

Dra Amanda Iglesias, DUE Rocio Cordova, Hospital Universitario Son Espases-IdISPa,

SECOND ANNUAL 3D ADVANCED FIBER DISSECTION COURSE: ACQUIRING THE MENTAL IMAGERY NECESSARY TO OPERATE THE BRAIN Santander, 26 th and 27 th October

V Barcelona International Congresson the. Mediterranean. Diet. Preliminar Programme March, 9, 10 and 11, 2004 in: Organized by:

26 November Lima, Perù

PRELIMINARY PROGRAMME

INTERNATIONAL SYMPOSIUM

Editorial Manager(tm) for Breast Cancer Research and Treatment Manuscript Draft

4-6 April 2018 XV UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY I INTERNATIONAL UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY

CLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES

ENYGO REPORT. Summary

HIV/HCV Coinfection in Spain: elimination is a stone's throw away

PROGNOSTIC FACTORS FOR RELAPSE IN STAGE I SEMINOMA: A NEW NOMOGRAM DERIVED FROM THREE CONSECUTIVE, RISK-ADAPTED STUDIES FROM THE SPANISH

Target audience This course is directed to physicians involved in diagnosis and treatment of lysosomal diseases.

1st Iberoamerican Congress of Neuropsychology. June 1-4, 2016, 2016 at the Bilbao Exhibition Centre - BEC

PROGRAMME April 26 th & 27 th 2019

The Journal of Heart and Lung Transplantation. 2007; 26(11):

Chair: W. Eberhardt, DE; S. Peters, CH. 12:00-13:00 Industry Satellite Symposium 1 (TBC) Room A. 13:30-13:45 Opening and Welcome Room B

Instituto Catalàn de Oncología, Hospital German Trias I Pujol, Badalona, Spain 5

Hepatitis C Eradication Reduces Liver Decompensation, HIV progression, and Death in HIV/HCV-coinfected Patients with non-advanced Liver Fibrosis

VASCULAR ACCESS SYMPOSIUM

THE PSA AND PROSTATE CANCER DILEMMA

Occupation-related differences in the prevalence of metabolic syndrome

Treating today s patients with tomorrow s solutions

Resistencias en cáncer de mama HER2 positivo, Hay margen para la mejora?

II Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN)

Cardiovascular Diseases (BMM9) and Getting to Know CNIC course Course

Wednesday, February 24 th, 2016

CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE

4-6 April 2018 XV UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY I INTERNATIONAL UPDATE COURSE IN ANGIOLOGY AND VASCULAR SURGERY

Impact of ERBB mutations on clinical outcomes in afatinib- or erlotinib-treated patients with SqCC of the lung

Conference Program. STS/EACTS Latin America Cardiovascular Surgery Conference. November 15-17, 2018 Cartagena, Colombia

ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS

Workshop: How to tackle the obesity epidemic in European children?

This meeting has been made possible by an independent grant from Roche.

Response Predicting Factors to Recombinant Human Erythropoietin in Cancer Patients Undergoing Platinum-Based Chemotherapy

Clinical. Update in Respiratory Medicine. International Symposium on. Barcelona (Spain) February 23 rd -24 th, 2018 FINAL PROGRAMME

October 12 13, 2018 New York Marriott Marquis New York, New York. The premier conference for annual updates in lung cancer. 23rd Annual Conference

Strategies to Reduce Premature Cardiovascular Morbidity and Mortality

A. Cano Sanchez J. Calaf i Alsina J.-L. Dueñas-Díez. Selective Estrogen Receptor Modulators. A New Brand of Multitarget Drugs

The Organizing Committee

III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins)

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

ESMO-Christie Lung Cancer Course

ASDEU Final Conference. Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain. 29th-30th January 2018

Best of WCLC- San Francisco

OVERVIEW IN NEUROONCOLOGY. CURRENT STATE IN THE MANAGEMENT OF BRAIN GLIOMAS AND NEW PERSPECTIVES. SECOND EDITION

VASCULAR ACCESS SYMPOSIUM

CNIO Friends. CNIO Friends 253. CNIO Friends Postdoctoral Contracts 254. Excelentes : a book of portraits on ideas that drive the world 255

PROGRAMME feb 2019 MADRID COURSE. 7 th MULTIDISCIPLINARY BONE AND SOFT TISSUE TUMORS MADRID COURSE. Dr. E.

FEBRUARY 17 TH. NAPLES Hotel Royal Continental. Director: Fortunato Ciardiello 6.6 CME Credits

4 TH ESO-ESMO LATIN-AMERICAN MASTERCLASS IN CLINICAL ONCOLOGY April 2018 Mexico City, Mexico LATIN-AMERICA PROGRAMME

DUAL: DarUnavir And Lamivudine

2 ND TRENDS IN GLAUCOMA

Transcription:

ORGANIZED BY FUNDACIÓN GECP

Thursday November 22 nd, 2018 10:00-10:30 Present situation and future: Spanish Lung Cancer Group The SLCG Thoracic Tumor Register (RTT) Dr. Mariano Provencio 10:30-10:50 ASEICA report on lung cancer in Spain Dr. Carlos Camps Hospital General Universitario, Valencia. CIBERONC 10:50-12:00 SESSION I - NSCLC: EARLY STAGES Dr. Manuel Cobo Hospital Universitario Carlos Haya, Málaga Dr. Rosario García-Campelo Complejo Hospitalario Universitario, A Coruña 10:50-11:05 TNM staging for lung cancer and future updates Dr. Antoni Rosell 11:05-11:25 Treating Stage I without surgery: SBRT Dr. Francisco Valcárcel 11:25-11:40 Postoperative chemotherapy Dr. Bartomeu Massutí Hospital General Universitario, Alicante 12:10-13:20 SESSION II - MOLECULAR BIOLOGY OF LUNG CANCER Dr. Carlos Camps Hospital General Universitario, Valencia. CIBERONC Dr. Noemí Reguart Hospital Clinic, Barcelona 12:10-12:15 Liquid biopsy in lung cancer: state of art Dr. Eloisa Jantus Hospital General Universitario, Valencia. CIBERONC 12:15-12:30 Next generation sequencing: how and when in lung cancer care? Dr. Atocha Romero 12:30-12:45 TMB. Practical approach Dr. Fatima Al Shahrour Spanish National Cancer Center (CNIO), Madrid 12:45-13:00 Different approaches for genomic analysis in lung cancer Dra. Clara Mayo Pangaea Oncology, Hospital Universitari Quirón Dexeus, Barcelona 13:00-13:20 Discussion 13:20-14:30 Lunch 11:40-12:00 Joint discussion 12:00-12:10 Break

14:30-15:10 SESSION III - CURRENT SPANISH LUNG CANCER GROUP TRIALS Dr. Ernest Nadal ICO, Hospital Durán i Reynals, L Hospitalet de Llobregat (Barcelona) Dr. Dolores Isla Hospital Clínico Universitario Lozano Blesa, Zaragoza 15:10-16:45 SESSION IV - NEW STRATEGIES IN SCLC AND OTHER THORACIC TUMORS Dr. Amelia Insa Hospital General Universitario, Valencia Dr. Manuel Dómine Hospital Universitario Fundación Jiménez Díaz, Madrid 15:10-15:25 Update in SCLC last year Dr. Javier de Castro Hospital Universitario La Paz, Madrid 15:25-15:40 Current role of radiotherapy in SCLC Dr. Antonio Gómez Caamaño Hospital Clínico Universitario de Santiago, Santiago de Compostela 15:40-15:55 Neuroendocrine tumors Dr. José Luis González-Larriba Hospital Clínico San Carlos, Madrid 15:55-16:15 Thymic tumors. New therapies for Malignant Mesothelioma Dr. Jordi Remón HM Delfos, Centro Integral Clara Campal, Barcelona 16:15-16:45 Discussion 16:45-17:00 Coffee Break

17:00-18:50 SESSION V - IMMUNOTHERAPY Dr. Carlos Carracedo ALIADAS, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú Dr. Aylen Vanessa Ospina Asociación Colombiana de Hematología y Oncología (ACHO) 17:00-17:15 Biomarkers in immunotherapy Dr. Joaquim Bosch Instituto Catalán de Oncología, Girona 17:15-17:35 Microbiota and immunotherapy Dr. M. Paula Roberti Institut Gustave Roussy, France 17:35-18:00 Inmunotherapy in first line? Dr. Delvys Rodríguez Abreu Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria 18:00-18:20 Toxicity management of inmuntherapy Dr. Reyes Bernabé Hospital Universitario Virgen del Rocío, Sevilla 18:20-18:50 Discussion Friday November 23 rd, 2018 08:30-09:30 SLCG Plenary Session 09:30-10:00 Snapshot of concurrent alterations in EGFR, ALK and ROS1 driven NSCLC Dr. Rafael Rosell 10:00-11:00 SESSION VI - LOCALLY ADVANCED DISEASE Dr. Ivana Sullivan Hospital de la Santa Creu i Sant Pau, Barcelona Dr. Pilar Lianes Hospital de Mataró, Mataró (Barcelona) 10:00-10:30 Controversy on the treatment of resectable stage III disease N2 persistent after neadjuvant In favour of surgery: Dr. Florentino Hernando-Trancho Hospital Clínico San Carlos, Madrid Against of surgery: Dr. Joaquín Casal Complejo Hospitalario Universitario de Vigo 10:30-10:45 New agents in locally advanced disease management. Dr. Teresa Morán 10:45-11:00 Discussion 11:00-11:30 Coffee Break

11:30-12:35 SESSION VII - CYTOTOXIC CHEMOTHERAPY FOR ADVANCED DISEASE Dr. Luis Paz-Ares Hospital Universitario 12 de octubre, Madrid Dr. Sergio Vázquez Hospital Universitario Lucus Augusti, Lugo 11:30-11:45 Role of chemotherapy in advanced disease: have we reached the bounds? Dr. Antonio Araujo Centro Hospitalar do Porto, Portugal 11:45-12:00 Molecular biology in advanced disease: beyond the targets Dr. Fernando López-Ríos HM Hospitales, Madrid 12:00-12:15 Making decisions in specific subpopulations: elderly and frail patients Dr. José M. Sánchez Hospital Universitario de la Princesa, Madrid 12:15-12:35 Discussion 12:35-13:40 SESSION VIII - LUNG CANCER ONCOGENIC DRIVERS Dr. Josefa Terrasa Hospital Universitario Son Espases, Palma de Mallorca Dr. Alfredo Sánchez Hospital Provincial de Castellón, Castellón 12:35-12:50 EGFR mutations beyond the first line therapy setting Dr. Enriqueta Felip Hospital Universitari Vall d Hebron, Barcelona 12:50-13:05 ALK translocations: can we establish a sequence of drugs? Dr. Enric Carcereny 13:05-13:20 T790M Dr. David Vicente Hospital Universitario Virgen Macarena, Sevilla 13:20-13:40 Discussion 13:40-14:00 Closing remarks

ORGANIZING AND SCIENTIFIC COMMITTEE Dr. Mariano Provencio SUPPORTING COMPANIES Platinum: Dr. Carlos Camps Hospital General Universitario, Valencia CIBERONC Dr. Enric Carcereny Dr. Bartomeu Massutí Hospital General Universitario, Alicante Dr. Ernest Nadal ICO, Hospital Durán i Reynals, L Hospitalet de Llobregat (Barcelona) Gold: Dr. Manuel Cobo Hospital General Universitario Carlos Haya, Málaga Dr. Ramón de las Peñas Consorcio Hospital Provincial, Castellón Dr. Manuel Domine Hopital Universitario Fundación Jiménez Díaz, Madrid Dra. María Rosario García Campelo Hospital Teresa Herrera, A Coruña Dr. Jose Luis Gonzalez Larriba Hospital Clínico San Carlos, Madrid Dra. Noemí Reguart Hospital Clinic, Barcelona Dr. Delvys Rodríguez Hospital Insular, Gran Canaria Silver: Bronze: Other Collaborators: Dra. Ivana Gabriela Sullivan Hospital Sant Pau, Barcelona

LANGUAGE Lectures will be delivered in English or in Spanish. VENUE Auditorio de la Mutua Madrileña Paseo de Eduardo Dato, 20 28010 Madrid Holding a badge will be required to access the meeting room. CREDITS Activitat acreditada pel Consell Català de la Formació Continuada de les Professions Sanitàries (CCFCPS) Comisión de Formación Continuada del Sistema Nacional de Salud con 1,4 CRÉDITS, expedient núm.: 09/023396-MD. UNDER THE AUSPICES OF SYMPOSIUM SECRETARIAT Monasterios de Suso y Yuso 34 28049 Madrid (+34) 91 372 02 03 e-mail: educationalsymposium@doctaforum.com www.gecp.org/educationalsymposium

2024 © healthdocbox.com Privacy Policy | Terms of Service | Feedback